Clinical Trial Update: Vernakalant Versus Flecainide: Atrial Contractility [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing vernakalant with flecainide to assess atrial contractility in atrial fibrillation; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Vernakalant (vernakalant)
• flecainide (flecainide)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN